Literature DB >> 25612011

Identification of secretaglobin Scgb2a1 as a target for developmental reprogramming by BPA in the rat prostate.

Rebecca Lee Yean Wong1, Quan Wang, Lindsey S Treviño, Maarten C Bosland, Jing Chen, Mario Medvedovic, Gail S Prins, Kurunthachalam Kannan, Shuk-Mei Ho, Cheryl Lyn Walker.   

Abstract

Secretoglobins are a superfamily of secreted proteins thought to participate in inflammation, tissue repair, and tumorigenesis. Secretoglobin family 2A member 1 (Scgb2a1) is a component of prostatein, a major androgen-binding protein secreted by the rat prostate. Using a rat model for developmental reprogramming of susceptibility to prostate carcinogenesis, we identified, by RNA-seq, that Scgb2a1 is significantly upregulated (>100-fold) in the prostate of adult rats neonatally exposed to bisphenol A (BPA), with increased gene expression confirmed by quantitative RT-PCR and chromatin immunoprecipitation for histone H3 lysine 9 acetylation. Bisulfite analysis of both CpG islands located within 10 kb of the Scgb2a1 promoter identified significant hypomethylation of the CpG island upstream of the transcription start site of this gene in the reprogrammed prostate. These data suggest that expression of Scgb2a1 in the adult prostate could be epigenetically reprogrammed by BPA exposure during prostate development, with potential implications for cancer risk and response to chemotherapeutics associated with prostatein binding.

Entities:  

Keywords:  BPA; BPA, Bisphenol A; ChIP, chromatin immunoprecipitation; DNA methylation; E, Estrogen; EDCs, Endocrine Disrupting Compounds; PIN, Prostatic Intraepithelial Neoplasia; RNA-seq, RNA-sequencing.; Scgb2a1; T, Testosterone; developmental reprogramming; prostate cancer; prostatein; qRT-PCR, quantitative real-time PCR

Mesh:

Substances:

Year:  2015        PMID: 25612011      PMCID: PMC4623267          DOI: 10.1080/15592294.2015.1009768

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  52 in total

Review 1.  Bisphenol A and human health: a review of the literature.

Authors:  Johanna R Rochester
Journal:  Reprod Toxicol       Date:  2013-08-30       Impact factor: 3.143

2.  Morphological and functional heterogeneity in the rat prostatic gland.

Authors:  N Hayashi; Y Sugimura; J Kawamura; A A Donjacour; G R Cunha
Journal:  Biol Reprod       Date:  1991-08       Impact factor: 4.285

3.  Quantitative determination of lobe specificity of mRNA expression of androgen-dependent genes in the rat prostate gland.

Authors:  Tomoharu Suzuki; Nariaki Fujimoto; Shigeyuki Kitamura; Shigeru Ohta
Journal:  Endocr J       Date:  2006-12-05       Impact factor: 2.349

4.  Environmental estrogens differentially engage the histone methyltransferase EZH2 to increase risk of uterine tumorigenesis.

Authors:  K Leigh Greathouse; Tiffany Bredfeldt; Jeffrey I Everitt; Kevin Lin; Tia Berry; Kurunthachalam Kannan; Megan L Mittelstadt; Shuk-mei Ho; Cheryl L Walker
Journal:  Mol Cancer Res       Date:  2012-04       Impact factor: 5.852

5.  MethPrimer: designing primers for methylation PCRs.

Authors:  Long-Cheng Li; Rajvir Dahiya
Journal:  Bioinformatics       Date:  2002-11       Impact factor: 6.937

6.  SCGB2A1 is a novel prognostic marker for colorectal cancer associated with chemoresistance and radioresistance.

Authors:  Koji Munakata; Mamoru Uemura; Ichiro Takemasa; Miyuki Ozaki; Masamitsu Konno; Junichi Nishimura; Taishi Hata; Tsunekazu Mizushima; Naotsugu Haraguchi; Shingo Noura; Masakazu Ikenaga; Shu Okamura; Mutsumi Fukunaga; Kohei Murata; Hirofumi Yamamoto; Yuichiro Doki; Masaki Mori
Journal:  Int J Oncol       Date:  2014-02-28       Impact factor: 5.650

7.  Maternal bisphenol-A levels at delivery: a looming problem?

Authors:  V Padmanabhan; K Siefert; S Ransom; T Johnson; J Pinkerton; L Anderson; L Tao; K Kannan
Journal:  J Perinatol       Date:  2008-02-14       Impact factor: 2.521

8.  Histopathological evidence for an association of inflammation with ductal pin-like lesions but not with ductal adenocarcinoma in the prostate of the noble rat.

Authors:  Jenni Bernoulli; Emrah Yatkin; Arto Laakso; Mikael Anttinen; Maarten Bosland; Katherine Vega; Markku Kallajoki; Risto Santti; Liisa Pylkkänen
Journal:  Prostate       Date:  2008-05-15       Impact factor: 4.104

9.  Induction at high incidence of ductal prostate adenocarcinomas in NBL/Cr and Sprague-Dawley Hsd:SD rats treated with a combination of testosterone and estradiol-17 beta or diethylstilbestrol.

Authors:  M C Bosland; H Ford; L Horton
Journal:  Carcinogenesis       Date:  1995-06       Impact factor: 4.944

Review 10.  Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity.

Authors:  Wade V Welshons; Kristina A Thayer; Barbara M Judy; Julia A Taylor; Edward M Curran; Frederick S vom Saal
Journal:  Environ Health Perspect       Date:  2003-06       Impact factor: 9.031

View more
  24 in total

1.  Stem Cells as Hormone Targets That Lead to Increased Cancer Susceptibility.

Authors:  Gail S Prins; Esther L Calderon-Gierszal; Wen-Yang Hu
Journal:  Endocrinology       Date:  2015-08-04       Impact factor: 4.736

2.  Impact of Drug Treatment at Neonatal Ages on Variability of Drug Metabolism and Drug-drug Interactions in Adult Life.

Authors:  Stephanie Piekos; Chad Pope; Austin Ferrara; Xiao-Bo Zhong
Journal:  Curr Pharmacol Rep       Date:  2017-01-03

3.  Genetic and epigenetic determinants of inter-individual variability in responses to toxicants.

Authors:  Lauren Lewis; Gregory E Crawford; Terrence S Furey; Ivan Rusyn
Journal:  Curr Opin Toxicol       Date:  2017-09-12

Review 4.  Minireview: Epigenomic Plasticity and Vulnerability to EDC Exposures.

Authors:  Cheryl Lyn Walker
Journal:  Mol Endocrinol       Date:  2016-06-29

Review 5.  Epigenetic impacts of endocrine disruptors in the brain.

Authors:  Deena M Walker; Andrea C Gore
Journal:  Front Neuroendocrinol       Date:  2016-09-20       Impact factor: 8.606

6.  Developmental exposure to endocrine disrupting chemicals alters the epigenome: Identification of reprogrammed targets.

Authors:  Lauren Prusinski; Ayman Al-Hendy; Qiwei Yang
Journal:  Gynecol Obstet Res       Date:  2016-05-03

7.  Data integration, analysis, and interpretation of eight academic CLARITY-BPA studies.

Authors:  Jerrold J Heindel; Scott Belcher; Jodi A Flaws; Gail S Prins; Shuk-Mei Ho; Jiude Mao; Heather B Patisaul; William Ricke; Cheryl S Rosenfeld; Ana M Soto; Frederick S Vom Saal; R Thomas Zoeller
Journal:  Reprod Toxicol       Date:  2020-07-16       Impact factor: 3.143

Review 8.  Multigenerational and transgenerational effects of endocrine disrupting chemicals: A role for altered epigenetic regulation?

Authors:  Frances Xin; Martha Susiarjo; Marisa S Bartolomei
Journal:  Semin Cell Dev Biol       Date:  2015-05-28       Impact factor: 7.727

9.  Gene expression and DNA methylation changes in the hypothalamus and hippocampus of adult rats developmentally exposed to bisphenol A or ethinyl estradiol: a CLARITY-BPA consortium study.

Authors:  Ana Cheong; Sarah A Johnson; Emily C Howald; Mark R Ellersieck; Luísa Camacho; Sherry M Lewis; Michelle M Vanlandingham; Jun Ying; Shuk-Mei Ho; Cheryl S Rosenfeld
Journal:  Epigenetics       Date:  2018-08-15       Impact factor: 4.528

Review 10.  EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals.

Authors:  A C Gore; V A Chappell; S E Fenton; J A Flaws; A Nadal; G S Prins; J Toppari; R T Zoeller
Journal:  Endocr Rev       Date:  2015-11-06       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.